193 related articles for article (PubMed ID: 14750783)
21. Triazenoindazoles and triazenopyrazolopyridines: design, synthesis, and cytotoxic activity.
Abdel-Hakeem M
Arch Pharm Res; 2010 Jun; 33(6):813-9. PubMed ID: 20607485
[TBL] [Abstract][Full Text] [Related]
22. Tridemethylisovelleral, a potent cytotoxic agent.
Aujard I; Röme D; Arzel E; Johansson M; de Vos D; Sterner O
Bioorg Med Chem; 2005 Nov; 13(22):6145-50. PubMed ID: 16055337
[TBL] [Abstract][Full Text] [Related]
23. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives.
Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
Jung M; Lee S; Ham J; Lee K; Kim H; Kim SK
J Med Chem; 2003 Mar; 46(6):987-94. PubMed ID: 12620075
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
[TBL] [Abstract][Full Text] [Related]
26. Conformationally restricted analogues of psorospermin: design, synthesis, and bioactivity of natural-product-related bisfuranoxanthones.
Heald RA; Dexheimer TS; Vankayalapati H; Siddiqui-Jain A; Szabo LZ; Gleason-Guzman MC; Hurley LH
J Med Chem; 2005 Apr; 48(8):2993-3004. PubMed ID: 15828838
[TBL] [Abstract][Full Text] [Related]
27. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Kelner MJ; McMorris TC; Rojas RJ; Trani NA; Estes L
Cancer Chemother Pharmacol; 2002 May; 49(5):412-8. PubMed ID: 11976836
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 1-substituted 3-(chloromethyl)-6-aminoindoline (6-amino-seco-CI) DNA minor groove alkylating agents and structure-activity relationships for their cytotoxicity.
Milbank JB; Tercel M; Atwell GJ; Wilson WR; Hogg A; Denny WA
J Med Chem; 1999 Feb; 42(4):649-58. PubMed ID: 10052972
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts.
van Laar ES; Izbicka E; Weitman S; Medina-Gundrum L; Macdonald JR; Waters SJ
Int J Gynecol Cancer; 2004; 14(5):824-31. PubMed ID: 15361190
[TBL] [Abstract][Full Text] [Related]
30. Activity of irofulven against human pancreatic carcinoma cell lines in vitro and in vivo.
Van Laar ES; Roth S; Weitman S; MacDonald JR; Waters SJ
Anticancer Res; 2004; 24(1):59-65. PubMed ID: 15015576
[TBL] [Abstract][Full Text] [Related]
31. BINOL-amino acid conjugates as triggerable carriers of DNA-targeted potent photocytotoxic agents.
Doria F; Richter SN; Nadai M; Colloredo-Mels S; Mella M; Palumbo M; Freccero M
J Med Chem; 2007 Dec; 50(26):6570-9. PubMed ID: 18047263
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of antitumor-active arglabin derivatives.
Csuk R; Heinold A; Siewert B; Schwarz S; Barthel A; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Mar; 345(3):215-22. PubMed ID: 21997763
[TBL] [Abstract][Full Text] [Related]
33. Chiral 6-hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: novel antitumor DNA monoalkylating agents.
Soares MI; Brito AF; Laranjo M; Abrantes AM; Botelho MF; Paixão JA; Beja AM; Silva MR; Pinho E Melo TM
Eur J Med Chem; 2010 Oct; 45(10):4676-81. PubMed ID: 20705366
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of conformationally constrained analogs of the antitumor agents XK469 and SH80. Part 5.
Hazeldine ST; Polin L; Kushner J; White K; Corbett TH; Horwitz JP
Bioorg Med Chem; 2006 Apr; 14(7):2462-7. PubMed ID: 16337128
[TBL] [Abstract][Full Text] [Related]
35. A novel stereocontrolled approach to eudesmanolides: total synthesis of (+/-)-gallicadiol and (+/-)-isogallicadiol.
Li WD; Gao ZH
Org Lett; 2005 Jul; 7(14):2917-20. PubMed ID: 15987169
[TBL] [Abstract][Full Text] [Related]
36. Antileukemic activity of aminoparthenolide analogs.
Nasim S; Crooks PA
Bioorg Med Chem Lett; 2008 Jul; 18(14):3870-3. PubMed ID: 18590961
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
[TBL] [Abstract][Full Text] [Related]
38. Cadinane sesquiterpenes from the leaves of Eupatorium adenophorum.
He L; Hou J; Gan M; Shi J; Chantrapromma S; Fun HK; Williams ID; Sung HH
J Nat Prod; 2008 Aug; 71(8):1485-8. PubMed ID: 18620454
[TBL] [Abstract][Full Text] [Related]
39. Irofulven (MGI Pharma).
Baekelandt M
Curr Opin Investig Drugs; 2002 Oct; 3(10):1517-26. PubMed ID: 12431030
[TBL] [Abstract][Full Text] [Related]
40. Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
Depauw S; Gaslonde T; Léonce S; Kraus-Berthier L; Laine W; Lenglet G; Chiaroni A; Pfeiffer B; Bailly C; Michel S; Tillequin F; Pierré A; David-Cordonnier MH
Mol Pharmacol; 2009 Dec; 76(6):1172-85. PubMed ID: 19752199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
